Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valomaciclovir in Infectious Mononucleosis
NCT00575185Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in infectious mononucleosis (IM) comparing Valomaciclovir with Placebo (2 arms). Primary endpoint: Number of Participants With Improvement in Clinical Symptoms and Reductions in Viral Burden From Baseline at 21 days. Started Nov 2007; status: completed.
02
Drugs
valomaciclovir
03
Conditions
infectious mononucleosis (IM)
Beyond the preview
Go deeper on NCT00575185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575185.